SPRAGUE JOHN M (Chief Financial Officer) exercised options at T2 BIOSYSTEMS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/23/2022ACC: 0000899243-22-007492
Officer· Chief Financial Officer
Since Jul 2018
+596.23K
Net shares
Net buyer
$1.8K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
610K acquired · 13.78K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
22.0%
2/21/2022
45.41K→55.41K
Common Stock
Direct
Shares
−3.77K
Price / share
$0.47
Trade value
$1.76K
% of position
7.7%
2/21/2022
49.26K→45.48K
Total
Net shares
+6.22K
Net value
-$1.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2022 | M · Option Exercise | +10K | — | — | 22.0% | 45.41K | 55.41K |
| Common Stock Direct | 2/21/2022 | F · Tax Withholding | −3.77K | $0.47 | $1.76K | 7.7% | 49.26K | 45.48K |
| Total | +6.22K | -$1.76K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
600K shares
Shares
+600K
Strike price
Held after
600K
Exercisable
—
2/20/2022
Restricted Stock Units
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
Held after
0.00
Exercisable
—
2/21/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock600K shares | 2/20/2022 | A · Award | +600K | — | 600K | |
| Restricted Stock Units Direct | Common Stock10K shares | 2/21/2022 | M · Option Exercise | −10K | — | 0.00 |